敗血症診断市場：動向、機会、競合分析【2023-2028年】

敗血症診断市場の動向と予測

世界の敗血症診断市場は、2023年から2028年までのCAGRが8.1%で、2028年までに推定10億米ドルに達すると予測されます。この市場の主な促進要因は、敗血症診断研究活動に対する官民の資金提供の増加、感染症リスクの上昇、敗血症発生件数の増加、人々の敗血症意識啓発に向けた政府の取り組みなどです。世界の敗血症診断市場の将来は、病院・診療所、病理・標準検査室、研究機関の各市場におけるビジネスチャンスによって有望視されています。

敗血症診断市場の洞察

• Lucintelは、高齢化人口の増加、血流感染症の増加、最も簡便で経済的に効率的な検査法として臨床医による採用が増加していることから、血液培養培地が予測期間中最大のセグメントであり続けると予測しています。
• この市場の中では、敗血症に罹患して病院を訪れる患者数の増加、様々な病気による死亡者数の増加、敗血症診断治療に使用できる様々な機器の入手可能性から、病院・診療所が最大のセグメントであり続けると思われます。
• 北米は、確立されたヘルスケアインフラの存在、先進的な診断ソリューションの採用の増加、敗血症や感染症の罹患率の増加により、予測期間中最大の地域であり続ける。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の敗血症診断市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2017年から2028年までの市場動向と予測分析

• マクロ経済動向（2017～2022年）と予測（2023～2028年）
• 世界の敗血症診断市場動向（2017-2022）と予測（2023-2028）
• 製品別の世界の敗血症診断市場
  • 楽器
  • 血液培養培地
  • アッセイキットと試薬
  • ソフトウェア
• 技術別の世界の敗血症診断市場
  • 微生物学
  • 分子診断学
  • 免疫学的検査
  • フローサイトメトリー
  • その他
• 最終用途産業別の世界の敗血症診断市場
  • 病院とクリニック
  • 病理学および基準研究所
  • 調査機関
  • その他

第4章 2017年から2028年までの地域別の市場動向と予測分析

• 地域別の世界の敗血症診断市場
• 北米の敗血症診断市場
• 欧州の敗血症診断市場
• アジア太平洋敗血症診断市場
• その他地域敗血症診断市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品別の世界の敗血症診断市場の成長機会
  • 技術による世界の敗血症診断市場の成長機会
  • 最終用途産業別の世界の敗血症診断市場の成長機会
  • 地域別の世界の敗血症診断市場の成長機会
• 世界の敗血症診断市場における新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の敗血症診断市場の能力拡大
  • 世界の敗血症診断市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• bioMerieux SA
• Becton, Dickinson & Company
• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Luminex
• Cepheid
• Bruker Corporation
• Immunexpress
• Koninklijke Philips

Sepsis Diagnostic Market Trends and Forecast

The future of the global sepsis diagnostic market looks promising with opportunities in the hospital & clinic, pathology & reference laboratory, and research institute markets. The global sepsis diagnostic market is expected to reach an estimated $1.0 billion by 2028 with a CAGR of 8.1% from 2023 to 2028. The major drivers for this market are growing public-private funding for sepsis diagnostic research activities, rising risk of infectious diseases, as well as increasing number of sepsis incidences, and government initiatives towards developing sepsis awareness among people.

A more than 150-page report is developed to help in your business decisions.

Sepsis Diagnostic Market by Segment

The study includes trends and forecast for the global sepsis diagnostic market by product, technology, end use industry, and region, as follows:

Sepsis Diagnostic Market by Product [Shipment Analysis by Value from 2017 to 2028]:

• Instruments
• Blood Culture Media
• Assay Kits and Reagents
• Software

Sepsis Diagnostic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry
• Others

Sepsis Diagnostic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

• Hospitals & Clinics
• Pathology & Reference Laboratories
• Research Institutes
• Others

Sepsis Diagnostic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Sepsis Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, sepsis diagnostic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the sepsis diagnostic companies profiled in this report include:

• bioMerieux SA
• Becton, Dickinson & Company
• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Luminex
• Cepheid
• Bruker Corporation
• Immunexpress
• Koninklijke Philips

Sepsis Diagnostic Market Insights

• Lucintel forecasts that blood culture media will remain the largest segment over the forecast period due to growing aging population, rising incidences of bloodstream infections and increasing adoption by the clinicians as it considered as the most convenient and economically efficient testing method.
• Within this market, hospitals & clinics will remain the largest segment due to growing number of patients visit in hospitals suffering from sepsis, huge number of fatalities caused by various illnesses, and the availability of various equipment, which can be used for sepsis diagnostic treatments.
• North America will remain the largest region over the forecast period due to existence of a well-established healthcare infrastructure, increasing adoption of advanced diagnostic solutions, and growing incidence of sepsis and infectious diseases in the region

Features of the Sepsis Diagnostic Market

• Market Size Estimates: Sepsis diagnostic market size estimation in terms of value ($B)
• Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
• Segmentation Analysis: Sepsis diagnostic market size by various segments, such as by product, technology, end use industry, and region
• Regional Analysis: Sepsis diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different products, technologies, end use industries, and regions for the sepsis diagnostic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape for the sepsis diagnostic market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q1. What is the sepsis diagnostic market size?
• Answer: The global sepsis diagnostic market is expected to reach an estimated $1.0 billion by 2028.
• Q2. What is the growth forecast for sepsis diagnostic market?
• Answer: The global sepsis diagnostic market is expected to grow with a CAGR of 8.1% from 2023 to 2028.
• Q3. What are the major drivers influencing the growth of the sepsis diagnostic market?
• Answer: The major drivers for this market are growing public-private funding for sepsis diagnostic research activities, rising risk of infectious diseases, as well as increasing number of sepsis incidences, and government initiatives towards developing sepsis awareness among people.
• Q4. What are the major segments for sepsis diagnostic market?
• Answer: The future of the global sepsis diagnostic market looks promising with opportunities in the hospital & clinic, pathology & reference laboratory, and research institute markets.
• Q5. Who are the key sepsis diagnostic companies?
• Answer: Some of the key sepsis diagnostic companies are as follows:
  • bioMerieux SA
  • Becton, Dickinson & Company
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Luminex
  • Cepheid
  • Bruker Corporation
  • Immunexpress
  • Koninklijke Philips
• Q6. Which sepsis diagnostic segment will be the largest in future?
• Answer:Lucintel forecast that blood culture media will remain the largest segment over the forecast period due to growing aging population, rising incidences of bloodstream infections and increasing adoption by the clinicians as it considered as the most convenient and economically efficient testing method.
• Q7. In sepsis diagnostic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to existence of a well-established healthcare infrastructure, increasing adoption of advanced diagnostic solutions, and growing incidence of sepsis and infectious diseases in the region.
• Q8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global sepsis diagnostic market by product (instruments, blood culture media, assay kits and reagents, and software), technology (microbiology, molecular diagnostics, immunoassays, flow cytometry, and others), end use industry (hospitals & clinics, pathology & reference laboratories, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Sepsis Diagnostic Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Global Sepsis Diagnostic Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Sepsis Diagnostic Market by Product
  • 3.3.1: Instruments
  • 3.3.2: Blood Culture Media
  • 3.3.3: Assay Kits and Reagents
  • 3.3.4: Software
• 3.4: Global Sepsis Diagnostic Market by Technology
  • 3.4.1: Microbiology
  • 3.4.2: Molecular Diagnostics
  • 3.4.3: Immunoassays
  • 3.4.4: Flow Cytometry
  • 3.4.5: Others
• 3.5: Global Sepsis Diagnostic Market by End Use Industry
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Pathology & Reference Laboratories
  • 3.5.3: Research Institutes
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Global Sepsis Diagnostic Market by Region
• 4.2: North American Sepsis Diagnostic Market
  • 4.2.1: North American Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
  • 4.2.2: North American Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others
• 4.3: European Sepsis Diagnostic Market
  • 4.3.1: European Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
  • 4.3.2: European Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others
• 4.4: APAC Sepsis Diagnostic Market
  • 4.4.1: APAC Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
  • 4.4.2: APAC Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others
• 4.5: ROW Sepsis Diagnostic Market
  • 4.5.1: ROW Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
  • 4.5.2: ROW Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Sepsis Diagnostic Market by Product
  • 6.1.2: Growth Opportunities for the Global Sepsis Diagnostic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Sepsis Diagnostic Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Sepsis Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Sepsis Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Sepsis Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Sepsis Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: bioMerieux SA
• 7.2: Becton, Dickinson & Company
• 7.3: Thermo Fisher Scientific
• 7.4: F. Hoffmann-La Roche
• 7.5: Danaher
• 7.6: Luminex
• 7.7: Cepheid
• 7.8: Bruker Corporation
• 7.9: Immunexpress
• 7.10: Koninklijke Philips